Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor
Joseph D. Buxbaum(Icahn School of Medicine at Mount Sinai), Roy A. Black(IDEX Corporation (United States)), Yuxia Luo(Icahn School of Medicine at Mount Sinai), Jennifer L. Slack, Richard S. Johnson, Douglas Pat Cerretti(Rutgers, The State University of New Jersey), Kang-Nian Liu(Icahn School of Medicine at Mount Sinai), Kim L. Stocking(IDEX Corporation (United States)), Beverly J. Castner, Jacques J. Peschon(University of Melbourne)
Cited by 916
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
An Essential Role for Ectodomain Shedding in Mammalian Development
|Science|1998|1.6k
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
|The Journal of Experimental Medicine|2000|1.6k